Shared on 04 Nov 25
Fair value Increased 1.15%The analyst price target for CVS Group has been raised by £4.00 per share to £19.00, as analysts highlight ongoing confidence in the company's outlook following recent adjustments to growth and profitability forecasts. Analyst Commentary Following the recent price target revision, analysts have provided a range of perspectives on the company’s valuation, execution, and growth outlook.
Shared on 21 Oct 25
Fair value Increased 6.37%Analysts Lift CVS Group Valuation Following Improved Growth and Dividend Announcement
Analysts have raised their price target for CVS Group from £15.44 to £16.43, citing improved revenue growth and profit margin expectations as key drivers for the upward revision. What's in the News The Board of CVS Group plc has recommended a final dividend payment of 8.5p per Ordinary share, an increase from 8.0p in 2024 (Key Developments).
Shared on 06 May 25
Fair value Increased 5.78%Expanding Into Australia And Improving Services Will Advance Future Veterinary Offerings
Shared on 01 May 25
Expanding Into Australia And Improving Services Will Advance Future Veterinary Offerings
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 23 Apr 25
Expanding Into Australia And Improving Services Will Advance Future Veterinary Offerings
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Expanding Into Australia And Improving Services Will Advance Future Veterinary Offerings
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Expanding Into Australia And Improving Services Will Advance Future Veterinary Offerings
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Decreased 1.35%Expanding Into Australia And Improving Services Will Advance Future Veterinary Offerings
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Increased 1.16%Expanding Into Australia And Improving Services Will Advance Future Veterinary Offerings
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Increased 4.43%Expanding Into Australia And Improving Services Will Advance Future Veterinary Offerings
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 12 Mar 25
Fair value Decreased 9.29%Expanding Into Australia And Improving Services Will Advance Future Veterinary Offerings
AnalystConsensusTarget made no meaningful changes to valuation assumptions.

